| American society of hematology, 51st annual meeting and exposition. | |
| | |
MedLine Citation:
|
PMID: 20221327 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
To further its mission of promoting the understanding, diagnosis, treatment, and prevention of blood disorders, the American Society of Hematology (ASH) hosted more than 21,000 attendees, including health care professionals, clinicians, guests, and about 3,600 exhibitors, in New Orleans from December 5 to 8, 2009. There were 978 oral presentations and about 3,100 poster presentations. In addition to trials of medications for chronic myelogenous leukemia, this article includes a review of selected evaluations of agents for less common blood disorders. |
| | |
Authors:
|
Walter Alexander |
Related Documents
:
|
20517537 - Recent advances in the management of thyroid cancer and type 2 diabetes: highlights fro... 21083457 - Hemophilia: basic and translational science. 20582867 - American society of gene & cell therapy--13th annual meeting. 11547507 - Human gene patents: core issues in a multi-layered debate. 17273307 - Are lcces exempt from income taxes? |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: P & T : a peer-reviewed journal for formulary management Volume: 35 ISSN: 1052-1372 ISO Abbreviation: P T Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-03-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9015516 Medline TA: P T Country: United States |
Other Details:
|
Languages: eng Pagination: 106-12 Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacological and clinical differences between low-molecular-weight heparins: implications for pre...
Next Document: A formalized teaching, practice, and research partnership with the veterans affairs north Texas heal...